KEGG   PATHWAY: lcm04020
Entry
lcm04020                    Pathway                                
Name
Calcium signaling pathway - Latimeria chalumnae (coelacanth)
Description
Ca2+ that enters the cell from the outside is a principal source of signal Ca2+. Entry of Ca2+ is driven by the presence of a large electrochemical gradient across the plasma membrane. Cells use this external source of signal Ca2+ by activating various entry channels with widely different properties. The voltage-operated channels (VOCs) are found in excitable cells and generate the rapid Ca2+ fluxes that control fast cellular processes. There are many other Ca2+-entry channels, such as the receptor-operated channels (ROCs), for example the NMDA (N-methyl-D-aspartate) receptors (NMDARs) that respond to glutamate. There also are second-messenger-operated channels (SMOCs) and store-operated channels (SOCs).
The other principal source of Ca2+ for signalling is the internal stores that are located primarily in the endoplasmic/sarcoplasmic reticulum (ER/SR), in which inositol-1,4,5-trisphosphate receptors (IP3Rs) or ryanodine receptors (RYRs) regulate the release of Ca2+. The principal activator of these channels is Ca2+ itself and this process of Ca2+-induced Ca2+ release is central to the mechanism of Ca2+ signalling. Various second messengers or modulators also control the release of Ca2+. IP3, which is generated by pathways using different isoforms of phospholipase C (PLCbeta, delta, epsilon, gamma and zeta), regulates the IP3Rs. Cyclic ADP-ribose (cADPR) releases Ca2+ via RYRs. Nicotinic acid adenine dinucleotide phosphate (NAADP) may activate a distinct Ca2+ release mechanism on separate acidic Ca2+ stores. Ca2+ release via the NAADP-sensitive mechanism may also feedback onto either RYRs or IP3Rs. cADPR and NAADP are generated by CD38. This enzyme might be sensitive to the cellular metabolism, as ATP and NADH inhibit it.
The influx of Ca2+ from the environment or release from internal stores causes a very rapid and dramatic increase in cytoplasmic calcium concentration, which has been widely exploited for signal transduction. Some proteins, such as troponin C (TnC) involved in muscle contraction, directly bind to and sense Ca2+. However, in other cases Ca2+ is sensed through intermediate calcium sensors such as calmodulin (CALM).
Class
Environmental Information Processing; Signal transduction
Pathway map
lcm04020  Calcium signaling pathway
lcm04020

Other DBs
GO: 0019722
Organism
Latimeria chalumnae (coelacanth) [GN:lcm]
Gene
102345110  PLCE1; phospholipase C epsilon 1 [KO:K05860] [EC:3.1.4.11]
102345121  FLT1; fms related tyrosine kinase 1 [KO:K05096] [EC:2.7.10.1]
102345296  FGFR4; fibroblast growth factor receptor 4 [KO:K05095] [EC:2.7.10.1]
102345389  FGF17; fibroblast growth factor 17 [KO:K04358]
102345610  CACNA1B; calcium voltage-gated channel subunit alpha1 B [KO:K04849]
102345800  PHKG1; phosphorylase kinase catalytic subunit gamma 1 [KO:K00871] [EC:2.7.11.19]
102345855  PLCB1; phospholipase C beta 1 [KO:K05858] [EC:3.1.4.11]
102345889  CAMK1G; calcium/calmodulin dependent protein kinase IG [KO:K08794] [EC:2.7.11.17]
102345954  ATP2B3; ATPase plasma membrane Ca2+ transporting 3 [KO:K05850] [EC:7.2.2.10]
102345989  [KO:K02183]
102346042  FGF16; fibroblast growth factor 16 [KO:K04358]
102346137  FGF8; fibroblast growth factor 8 [KO:K04358]
102346191  [KO:K04137]
102346192  [KO:K16057]
102346368  [KO:K05221]
102346458  CAMK2G; calcium/calmodulin dependent protein kinase II gamma [KO:K04515] [EC:2.7.11.17]
102346479  [KO:K05850] [EC:7.2.2.10]
102346544  [KO:K04348] [EC:3.1.3.16]
102346555  ADRA1A; alpha-1A adrenergic receptor [KO:K04135]
102346737  ADCY8; adenylate cyclase 8 [KO:K08048] [EC:4.6.1.1]
102346773  P2RX4; purinergic receptor P2X 4 [KO:K05218]
102346942  [KO:K04222]
102346967  MYLK3; myosin light chain kinase 3 [KO:K00907] [EC:2.7.11.18]
102347011  SLC25A5; solute carrier family 25 member 5 [KO:K05863]
102347085  GRIN3B; glutamate ionotropic receptor NMDA type subunit 3B [KO:K05214]
102347106  [KO:K04163]
102347246  CALM1; calmodulin 1 [KO:K02183]
102347262  [KO:K04163]
102347333  DRD1; dopamine receptor D1 [KO:K04144]
102347407  P2RX3; purinergic receptor P2X 3 [KO:K05217]
102347487  CYSLTR2; cysteinyl leukotriene receptor 2 [KO:K04323]
102347510  [KO:K05840]
102347545  TBXA2R; thromboxane A2 receptor [KO:K04264]
102347582  VEGFB; vascular endothelial growth factor B [KO:K05448]
102347584  [KO:K05861] [EC:3.1.4.11]
102347663  PDE1B; phosphodiesterase 1B [KO:K13755] [EC:3.1.4.17]
102347667  AGTR1; angiotensin II receptor type 1 [KO:K04166]
102347694  SLC8A3; solute carrier family 8 member A3 [KO:K05849]
102347797  PLCD1; phospholipase C delta 1 [KO:K05857] [EC:3.1.4.11]
102347939  [KO:K05853] [EC:7.2.2.10]
102348275  PLCB4; phospholipase C beta 4 [KO:K05858] [EC:3.1.4.11]
102348281  NOS1; nitric oxide synthase 1 [KO:K13240] [EC:1.14.13.39]
102348328  PDE1A; phosphodiesterase 1A [KO:K13755] [EC:3.1.4.17]
102348461  [KO:K04135]
102348516  ORAI3; ORAI calcium release-activated calcium modulator 3 [KO:K16057]
102348525  HTR6; 5-hydroxytryptamine receptor 6 [KO:K04162]
102348549  P2RX1; purinergic receptor P2X 1 [KO:K05215]
102348562  PLCD3; phospholipase C delta 3 [KO:K05857] [EC:3.1.4.11]
102348733  [KO:K04160]
102348800  [KO:K04357]
102348821  ERBB2; erb-b2 receptor tyrosine kinase 2 [KO:K05083] [EC:2.7.10.1]
102348900  NTRK3; neurotrophic receptor tyrosine kinase 3 [KO:K05101] [EC:2.7.10.1]
102348955  ADORA2A; adenosine A2a receptor [KO:K04266]
102348977  TACR2; tachykinin receptor 2 [KO:K04223]
102349003  HRH2; histamine receptor H2 [KO:K04150]
102349199  HTR4; 5-hydroxytryptamine receptor 4 [KO:K04160]
102349231  BDKRB2; bradykinin receptor B2 [KO:K03916]
102349426  HTR7; 5-hydroxytryptamine receptor 7 [KO:K04163]
102349456  CACNA1H; calcium voltage-gated channel subunit alpha1 H [KO:K04855]
102349602  PTAFR; platelet activating factor receptor [KO:K04279]
102349626  [KO:K04157]
102349731  [KO:K05863]
102349822  [KO:K05857] [EC:3.1.4.11]
102349825  ITPR3; inositol 1,4,5-trisphosphate receptor type 3 [KO:K04960]
102349897  F2R; coagulation factor II thrombin receptor [KO:K03914]
102349900  [KO:K04149]
102349922  FGF18; fibroblast growth factor 18 [KO:K04358]
102349925  FGFR2; fibroblast growth factor receptor 2 [KO:K05093] [EC:2.7.10.1]
102349968  [KO:K04446]
102350112  NFATC1; nuclear factor of activated T-cells, cytoplasmic 1 [KO:K04446]
102350126  ITPKB; inositol-trisphosphate 3-kinase B [KO:K00911] [EC:2.7.1.127]
102350139  [KO:K12042]
102350158  SLC25A31; solute carrier family 25 member 31 [KO:K05863]
102350376  CASQ2; calsequestrin 2 [KO:K23445]
102350498  ITPKC; inositol-trisphosphate 3-kinase A [KO:K00911] [EC:2.7.1.127]
102350599  VDAC1; voltage dependent anion channel 1 [KO:K05862]
102350955  SPHK1; sphingosine kinase 1 [KO:K04718] [EC:2.7.1.91]
102351065  ADCY7; adenylate cyclase 7 [KO:K08047] [EC:4.6.1.1]
102351067  FGF7; fibroblast growth factor 7 [KO:K04358]
102351365  TNNC1; troponin C1, slow skeletal and cardiac type [KO:K05865]
102351407  FGF2; fibroblast growth factor 2 [KO:K18497]
102351552  CHRM2; cholinergic receptor muscarinic 2 [KO:K04130]
102351685  PDGFD; platelet derived growth factor D [KO:K05450]
102351727  FGF23; fibroblast growth factor 23 [KO:K22428]
102351759  GNAL; G protein subunit alpha L [KO:K04633]
102352059  MST1; macrophage stimulating 1 [KO:K23441]
102352144  TRHR; thyrotropin releasing hormone receptor [KO:K04282]
102352170  [KO:K12042]
102352226  FGF20; fibroblast growth factor 20 [KO:K04358]
102352251  [KO:K00907] [EC:2.7.11.18]
102352260  PRKCG; protein kinase C gamma [KO:K19663] [EC:2.7.11.13]
102352270  [KO:K04348] [EC:3.1.3.16]
102352362  P2RX7; P2X purinoceptor 4 [KO:K05220]
102352409  GNA11; guanine nucleotide-binding protein subunit alpha-11 [KO:K04634]
102352427  NFATC4; nuclear factor of activated T-cells 4 [KO:K17334]
102352483  GNAS; GNAS complex locus [KO:K04632]
102352709  CACNA1I; calcium voltage-gated channel subunit alpha1 I [KO:K04856]
102352804  [KO:K01116] [EC:3.1.4.11]
102352812  FGF6; fibroblast growth factor 6 [KO:K04358]
102352946  PDGFA; platelet derived growth factor subunit A [KO:K04359]
102352958  NFATC2; nuclear factor of activated T-cells 2 [KO:K17332]
102352969  [KO:K04297]
102353071  [KO:K04348] [EC:3.1.3.16]
102353211  HTR2B; 5-hydroxytryptamine receptor 2B [KO:K04157]
102353223  CASQ1; calsequestrin 1 [KO:K23468]
102353236  CACNA1F; calcium voltage-gated channel subunit alpha1 F [KO:K04853]
102353242  ATP2B1; plasma membrane calcium-transporting ATPase 1 [KO:K05850] [EC:7.2.2.10]
102353265  RYR2; ryanodine receptor 2 [KO:K04962]
102353488  FGF10; fibroblast growth factor 10 [KO:K04358]
102353564  [KO:K05865]
102353616  ERBB3; erb-b2 receptor tyrosine kinase 3 [KO:K05084] [EC:2.7.10.1]
102353646  ADORA2B; adenosine receptor A2b [KO:K04267]
102353650  [KO:K10785]
102353683  SLC8A2; solute carrier family 8 member A2 [KO:K05849]
102353753  PDGFRA; platelet derived growth factor receptor alpha [KO:K04363] [EC:2.7.10.1]
102353814  TFEB; transcription factor EB [KO:K15590]
102354132  NTRK1; neurotrophic receptor tyrosine kinase 1 [KO:K03176] [EC:2.7.10.1]
102354206  HGF; hepatocyte growth factor [KO:K05460]
102354402  PLCD4; phospholipase C delta 4 [KO:K05857] [EC:3.1.4.11]
102354569  TRDN; triadin [KO:K23449]
102354805  [KO:K04322]
102354855  CACNA1A; calcium voltage-gated channel subunit alpha1 A [KO:K04344]
102354990  NOS2; nitric oxide synthase 2 [KO:K13241] [EC:1.14.13.39]
102355138  FGF1; fibroblast growth factor 1 [KO:K18496]
102355205  P2RX2; purinergic receptor P2X 2 [KO:K05216]
102355261  DRD5; dopamine receptor D5 [KO:K05840]
102355334  GRIN2B; glutamate ionotropic receptor NMDA type subunit 2B [KO:K05210]
102355435  PDGFB; platelet derived growth factor subunit B [KO:K17386]
102355670  SLN; sarcolipin [KO:K22642]
102355776  [KO:K00476] [EC:1.14.11.16]
102355816  STIM2; stromal interaction molecule 2 [KO:K18196]
102355997  PTGER3; prostaglandin E receptor 3 [KO:K04260]
102356038  GRIN1; glutamate ionotropic receptor NMDA type subunit 1 [KO:K05208]
102356049  [KO:K00476] [EC:1.14.11.16]
102356182  [KO:K04358]
102356282  NFATC3; nuclear factor of activated T-cells 3 [KO:K17333]
102356360  RYR1; ryanodine receptor 1 [KO:K04961]
102356453  EDNRA; endothelin receptor type A [KO:K04197]
102356509  PDGFC; platelet derived growth factor C [KO:K05450]
102356552  SLC25A4; solute carrier family 25 member 4 [KO:K05863]
102356715  CACNA1S; calcium voltage-gated channel subunit alpha1 S [KO:K04857]
102356822  EGF; epidermal growth factor [KO:K04357]
102357093  NTSR2; neurotensin receptor 2 [KO:K04211]
102357200  HTR2A; 5-hydroxytryptamine receptor 2A [KO:K04157]
102357437  [KO:K05840]
102357445  GRPR; gastrin releasing peptide receptor [KO:K04169]
102357596  [KO:K04161]
102357629  PTGFR; prostaglandin F receptor [KO:K04262]
102357941  CACNA1C; calcium voltage-gated channel subunit alpha1 C [KO:K04850]
102357981  FGF5; fibroblast growth factor 5 [KO:K04358]
102358132  PLCG2; phospholipase C gamma 2 [KO:K05859] [EC:3.1.4.11]
102358221  [KO:K04198]
102358285  RET; ret proto-oncogene [KO:K05126] [EC:2.7.10.1]
102358420  VDAC3; voltage dependent anion channel 3 [KO:K15041]
102358533  SLC8A1; solute carrier family 8 member A1 [KO:K05849]
102358983  TPCN1; two pore segment channel 1 [KO:K16896]
102359097  GRM1; glutamate metabotropic receptor 1 [KO:K04603]
102359098  ATP2B2; plasma membrane calcium-transporting ATPase 2 [KO:K05850] [EC:7.2.2.10]
102359367  GRIN2A; glutamate ionotropic receptor NMDA type subunit 2A [KO:K05209]
102359416  GNAQ; guanine nucleotide-binding protein G(q) subunit alpha [KO:K04634]
102359609  CAMK1; calcium/calmodulin dependent protein kinase I [KO:K08794] [EC:2.7.11.17]
102359693  CALML4; calmodulin like 4 [KO:K02183]
102359711  CALM2; calmodulin 2 [KO:K02183]
102359750  FGF22; fibroblast growth factor 22 [KO:K04358]
102359808  [KO:K04266]
102359855  PRKACB; protein kinase cAMP-activated catalytic subunit beta [KO:K04345] [EC:2.7.11.11]
102359880  ITPR2; inositol 1,4,5-trisphosphate receptor type 2 [KO:K04959]
102359969  ADRB1; adrenoceptor beta 1 [KO:K04141]
102359993  FLT4; fms related tyrosine kinase 4 [KO:K05097] [EC:2.7.10.1]
102360047  STIM1; stromal interaction molecule 1 [KO:K16059]
102360076  [KO:K04515] [EC:2.7.11.17]
102360220  ERBB4; erb-b2 receptor tyrosine kinase 4 [KO:K05085] [EC:2.7.10.1]
102360221  FGF4; fibroblast growth factor 4 [KO:K04358]
102360263  CAMK2B; calcium/calmodulin-dependent protein kinase type II subunit beta [KO:K04515] [EC:2.7.11.17]
102360486  FGF19; fibroblast growth factor 19 [KO:K22603]
102360711  [KO:K05449]
102360791  [KO:K02183]
102360815  CACNA1D; calcium voltage-gated channel subunit alpha1 D [KO:K04851]
102361014  FGFR1; fibroblast growth factor receptor 1 [KO:K04362] [EC:2.7.10.1]
102361104  ITPKA; inositol-trisphosphate 3-kinase A [KO:K00911] [EC:2.7.1.127]
102361208  CXCR4; C-X-C motif chemokine receptor 4 [KO:K04189]
102361238  [KO:K08794] [EC:2.7.11.17]
102361286  [KO:K02183]
102361301  ITPR1; inositol 1,4,5-trisphosphate receptor type 1 [KO:K04958]
102361386  PDGFRB; platelet derived growth factor receptor beta [KO:K05089] [EC:2.7.10.1]
102361410  PPP3CC; protein phosphatase 3 catalytic subunit gamma [KO:K04348] [EC:3.1.3.16]
102361415  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]
102361433  VEGFD; vascular endothelial growth factor D [KO:K05449]
102361440  [KO:K05869] [EC:2.7.11.17]
102361591  P2RX5; purinergic receptor P2X 5 [KO:K05219]
102361646  CAMK2A; calcium/calmodulin dependent protein kinase II alpha [KO:K04515] [EC:2.7.11.17]
102361733  ATP2A1; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1 [KO:K05853] [EC:7.2.2.10]
102361800  TPCN2; two pore segment channel 2 [KO:K14077]
102361888  CHRM3; cholinergic receptor muscarinic 3 [KO:K04131]
102361981  ADRB3; adrenoceptor beta 3 [KO:K04143]
102362118  EDNRB; endothelin receptor type B [KO:K04198]
102362167  CAMK4; calcium/calmodulin-dependent protein kinase type IV [KO:K05869] [EC:2.7.11.17]
102362179  [KO:K09565] [EC:5.2.1.8]
102362201  CACNA1E; calcium voltage-gated channel subunit alpha1 E [KO:K04852]
102362364  PLCB2; phospholipase C beta 2 [KO:K05858] [EC:3.1.4.11]
102362398  MCOLN3; mucolipin-3 [KO:K04994]
102362416  PLN; phospholamban [KO:K05852]
102362417  AVPR1A; arginine vasopressin receptor 1A [KO:K04226]
102362442  PLCG1; phospholipase C gamma 1 [KO:K01116] [EC:3.1.4.11]
102362466  [KO:K03914]
102362535  FGF9; fibroblast growth factor 9 [KO:K04358]
102362563  [KO:K00871] [EC:2.7.11.19]
102362684  KDR; kinase insert domain receptor [KO:K05098] [EC:2.7.10.1]
102362748  [KO:K04142]
102362835  [KO:K04809]
102362951  [KO:K04345] [EC:2.7.11.11]
102362968  HTR5A; 5-hydroxytryptamine receptor 5A [KO:K04161]
102363016  [KO:K08794] [EC:2.7.11.17]
102363070  GDNF; glial cell derived neurotrophic factor [KO:K05452]
102363165  OXTR; oxytocin receptor [KO:K04229]
102363182  ADCY9; adenylate cyclase 9 [KO:K08049] [EC:4.6.1.1]
102363403  PTGER1; prostaglandin E receptor 1 [KO:K04258]
102363863  CHRM5; cholinergic receptor muscarinic 5 [KO:K04133]
102363882  NTRK2; neurotrophic receptor tyrosine kinase 2 [KO:K04360] [EC:2.7.10.1]
102363964  PPP3CA; serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform [KO:K04348] [EC:3.1.3.16]
102364131  RYR3; ryanodine receptor 3 [KO:K04963]
102364322  NGF; nerve growth factor [KO:K02582]
102364583  FGFR3; fibroblast growth factor receptor 3 [KO:K05094] [EC:2.7.10.1]
102364636  CCKAR; cholecystokinin A receptor [KO:K04194]
102364726  CACNA1G; calcium voltage-gated channel subunit alpha1 G [KO:K04854]
102364762  PTK2B; protein tyrosine kinase 2 beta [KO:K05871] [EC:2.7.10.2]
102364780  [KO:K01242] [EC:3.2.2.6 2.4.99.20]
102364799  FGF3; fibroblast growth factor 3 [KO:K04358]
102364888  GRIN2C; glutamate ionotropic receptor NMDA type subunit 2C [KO:K05211]
102364905  MCOLN1; mucolipin 1 [KO:K04992]
102364971  PRKCB; protein kinase C beta [KO:K19662] [EC:2.7.11.13]
102365417  GRIN2D; glutamate ionotropic receptor NMDA type subunit 2D [KO:K05212]
102365455  ORAI1; ORAI calcium release-activated calcium modulator 1 [KO:K16056]
102365485  [KO:K05096] [EC:2.7.10.1]
102365504  [KO:K04282]
102365542  PLCB3; phospholipase C beta 3 [KO:K05858] [EC:3.1.4.11]
102365586  CYSLTR1; cysteinyl leukotriene receptor 1 [KO:K04322]
102365947  [KO:K08042] [EC:4.6.1.1]
102366006  MET; MET proto-oncogene, receptor tyrosine kinase [KO:K05099] [EC:2.7.10.1]
102366118  MCU; mitochondrial calcium uniporter [KO:K20858]
102366146  CHRNA7; cholinergic receptor nicotinic alpha 7 subunit [KO:K04809]
102366576  CHRM1; cholinergic receptor muscarinic 1 [KO:K04129]
102366698  ATP2A2; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 [KO:K05853] [EC:7.2.2.10]
102366722  PDE1C; calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C [KO:K13755] [EC:3.1.4.17]
102366723  VDAC2; voltage dependent anion channel 2 [KO:K15040]
102366778  MCOLN2; mucolipin 2 [KO:K04993]
102366907  CALML6; calmodulin like 6 [KO:K02183]
102366976  GRIN3A; glutamate ionotropic receptor NMDA type subunit 3A [KO:K05213]
102367010  NTSR1; neurotensin receptor 1 [KO:K04211]
102367077  VEGFC; vascular endothelial growth factor C [KO:K05449]
102367139  LHCGR; lutropin-choriogonadotropic hormone receptor [KO:K04248]
102367148  ADRA1B; adrenoceptor alpha 1B [KO:K04136]
102367157  PPP3R1; protein phosphatase 3 regulatory subunit B, alpha [KO:K06268]
102367170  [KO:K08042] [EC:4.6.1.1]
102367184  TGFA; transforming growth factor alpha [KO:K08774]
102367258  SPHK2; sphingosine kinase 2 [KO:K04718] [EC:2.7.1.91]
102367264  VEGFA; vascular endothelial growth factor A [KO:K05448]
102367281  [KO:K05849]
102367479  [KO:K05853] [EC:7.2.2.10]
102367522  [KO:K09565] [EC:5.2.1.8]
102367592  AVPR1B; arginine vasopressin receptor 1B [KO:K04227]
106703882  [KO:K04266]
106704494  [KO:K10785]
106705384  [KO:K04149]
106705460  TACR3; neuromedin-K receptor-like [KO:K04224]
106706579  [KO:K01242] [EC:3.2.2.6 2.4.99.20]
Compound
C00002  ATP
C00004  NADH
C00076  Calcium cation
C00165  Diacylglycerol
C00575  3',5'-Cyclic AMP
C01245  D-myo-Inositol 1,4,5-trisphosphate
C01330  Sodium cation
C06124  Sphingosine 1-phosphate
C11556  1-Phosphatidyl-1D-myo-inositol 3,5-bisphosphate
C13050  Cyclic ADP-ribose
C13051  Nicotinic acid adenine dinucleotide phosphate
Reference
  Authors
Berridge MJ, Bootman MD, Roderick HL.
  Title
Calcium signalling: dynamics, homeostasis and remodelling.
  Journal
Nat Rev Mol Cell Biol 4:517-29 (2003)
DOI:10.1038/nrm1155
Reference
  Authors
Berridge MJ, Lipp P, Bootman MD.
  Title
The versatility and universality of calcium signalling.
  Journal
Nat Rev Mol Cell Biol 1:11-21 (2000)
DOI:10.1038/35036035
Reference
  Authors
Wang MC, Dolphin A, Kitmitto A.
  Title
L-type voltage-gated calcium channels: understanding function through structure.
  Journal
FEBS Lett 564:245-50 (2004)
DOI:10.1016/S0014-5793(04)00253-4
Reference
  Authors
Ferrier GR, Howlett SE.
  Title
Cardiac excitation-contraction coupling: role of membrane potential in regulation of contraction.
  Journal
Am J Physiol Heart Circ Physiol 280:H1928-44 (2001)
DOI:10.1152/ajpheart.2001.280.5.H1928
Reference
  Authors
Keef KD, Hume JR, Zhong J.
  Title
Regulation of cardiac and smooth muscle Ca(2+) channels (Ca(V)1.2a,b) by protein kinases.
  Journal
Am J Physiol Cell Physiol 281:C1743-56 (2001)
DOI:10.1152/ajpcell.2001.281.6.C1743
Reference
PMID:8125957
  Authors
Hell JW, Appleyard SM, Yokoyama CT, Warner C, Catterall WA.
  Title
Differential phosphorylation of two size forms of the N-type calcium channel alpha 1 subunit which have different COOH termini.
  Journal
J Biol Chem 269:7390-6 (1994)
Reference
  Authors
Yunker AM.
  Title
Modulation and pharmacology of low voltage-activated ("T-Type") calcium channels.
  Journal
J Bioenerg Biomembr 35:577-98 (2003)
DOI:10.1023/B:JOBB.0000008025.65675.37
Reference
PMID:9149541
  Authors
Yakel JL.
  Title
Calcineurin regulation of synaptic function: from ion channels to transmitter release and gene transcription.
  Journal
Trends Pharmacol Sci 18:124-34 (1997)
DOI:10.1016/S0165-6147(97)01046-8
Reference
  Authors
Fukunaga K, Miyamoto E.
  Title
A working model of CaM kinase II activity in hippocampal long-term potentiation and memory.
  Journal
Neurosci Res 38:3-17 (2000)
DOI:10.1016/S0168-0102(00)00139-5
Reference
PMID:9235901
  Authors
Della Rocca GJ, van Biesen T, Daaka Y, Luttrell DK, Luttrell LM, Lefkowitz RJ.
  Title
Ras-dependent mitogen-activated protein kinase activation by G protein-coupled receptors. Convergence of Gi- and Gq-mediated pathways on calcium/calmodulin, Pyk2, and Src kinase.
  Journal
J Biol Chem 272:19125-32 (1997)
DOI:10.1074/jbc.272.31.19125
Reference
PMID:7861177
  Authors
Furuichi T, Mikoshiba K.
  Title
Inositol 1, 4, 5-trisphosphate receptor-mediated Ca2+ signaling in the brain.
  Journal
J Neurochem 64:953-60 (1995)
DOI:10.1046/j.1471-4159.1995.64030953.x
Reference
  Authors
Bruce JI, Straub SV, Yule DI.
  Title
Crosstalk between cAMP and Ca2+ signaling in non-excitable cells.
  Journal
Cell Calcium 34:431-44 (2003)
DOI:10.1016/S0143-4160(03)00150-7
Reference
  Authors
Lee HC, Munshi C, Graeff R.
  Title
Structures and activities of cyclic ADP-ribose, NAADP and their metabolic enzymes.
  Journal
Mol Cell Biochem 193:89-98 (1999)
DOI:10.1007/978-1-4419-8740-2_13
Reference
  Authors
Crompton M.
  Title
Mitochondrial intermembrane junctional complexes and their role in cell death.
  Journal
J Physiol 529 Pt 1:11-21 (2000)
DOI:10.1111/j.1469-7793.2000.00011.x
Reference
  Authors
Grewal SS, York RD, Stork PJ.
  Title
Extracellular-signal-regulated kinase signalling in neurons.
  Journal
Curr Opin Neurobiol 9:544-53 (1999)
DOI:10.1016/S0959-4388(99)00010-0
Reference
  Authors
Trushin SA, Pennington KN, Carmona EM, Asin S, Savoy DN, Billadeau DD, Paya CV.
  Title
Protein kinase Calpha (PKCalpha) acts upstream of PKCtheta to activate IkappaB kinase and NF-kappaB in T lymphocytes.
  Journal
Mol Cell Biol 23:7068-81 (2003)
DOI:10.1128/MCB.23.19.7068-7081.2003
Reference
  Authors
Hutchins JR, Dikovskaya D, Clarke PR.
  Title
Regulation of Cdc2/cyclin B activation in Xenopus egg extracts via inhibitory phosphorylation of Cdc25C phosphatase by Ca(2+)/calmodulin-dependent protein [corrected] kinase II.
  Journal
Mol Biol Cell 14:4003-14 (2003)
DOI:10.1091/mbc.E03-02-0061
Reference
  Authors
Tornquist K
  Title
Sphingosine 1-phosphate, sphingosine kinase and autocrine calcium signalling in thyroid cells.
  Journal
Acta Physiol (Oxf) 204:151-7 (2012)
DOI:10.1111/j.1748-1716.2011.02265.x
Reference
  Authors
Feske S
  Title
Immunodeficiency due to defects in store-operated calcium entry.
  Journal
Ann N Y Acad Sci 1238:74-90 (2011)
DOI:10.1111/j.1749-6632.2011.06240.x
Reference
  Authors
Giachini FR, Lima VV, Hannan JL, Carneiro FS, Webb RC, Tostes RC
  Title
STIM1/Orai1-mediated store-operated Ca2+ entry: the tip of the iceberg.
  Journal
Braz J Med Biol Res 44:1080-7 (2011)
DOI:10.1590/S0100-879X2011007500133
Reference
  Authors
Baba Y, Kurosaki T
  Title
[Regulation of store-operated calcium entry by STIM1].
  Journal
Seikagaku 80:1123-8 (2008)
Reference
  Authors
Galione A, Evans AM, Ma J, Parrington J, Arredouani A, Cheng X, Zhu MX
  Title
The acid test: the discovery of two-pore channels (TPCs) as NAADP-gated endolysosomal Ca(2+) release channels.
  Journal
Pflugers Arch 458:869-76 (2009)
DOI:10.1007/s00424-009-0682-y
Reference
  Authors
Beard NA, Wei L, Dulhunty AF
  Title
Ca(2+) signaling in striated muscle: the elusive roles of triadin, junctin, and calsequestrin.
  Journal
Eur Biophys J 39:27-36 (2009)
DOI:10.1007/s00249-009-0449-6
Reference
  Authors
Marty I
  Title
Triadin regulation of the ryanodine receptor complex.
  Journal
J Physiol 593:3261-6 (2015)
DOI:10.1113/jphysiol.2014.281147
Reference
  Authors
Arvanitis DA, Vafiadaki E, Sanoudou D, Kranias EG
  Title
Histidine-rich calcium binding protein: the new regulator of sarcoplasmic reticulum calcium cycling.
  Journal
J Mol Cell Cardiol 50:43-9 (2011)
DOI:10.1016/j.yjmcc.2010.08.021
Related
pathway
lcm04010  MAPK signaling pathway
lcm04070  Phosphatidylinositol signaling system
lcm04210  Apoptosis
KO pathway
ko04020   

DBGET integrated database retrieval system